Ultima Genomics announces that it will provide three trillion DNA sequencing reads free of charge to researchers across the ...

CHICAGO – Henry Ford Health and Illumina have enrolled the first 1,000 patients into CardioSeq, a clinical trial assessing the clinical utility of whole-genome sequencing in cardiovascular care. So ...

Keith Meister, Corvex Management’s chief investment officer, will join Illumina’s board starting March 28. He’s no stranger ...

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue from China, after the country banned the importation of its DNA ...

Illumina (NASDAQ:ILMN) on Monday lowered its adjusted profit outlook and cut spending costs for 2025 as the company grapples with a Chinese ban on its gene sequencers. Illumina now expects fiscal ...

Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing instruments into China. Illumina said it “respects ...

Illumina (ILMN) said it is instituting an incremental approximately $100M cost reduction program for fiscal 2025. The company added, “These savings would mitigate the impact of a range of ...

In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other large-cap stocks. The big and large-cap stocks have spearheaded the rally in the past ...

Successfully used in several NGS systems including Illumina (HiSeq/miSeq), Roche (454) and Thermo Fisher (Ion Torrent™ and Ion Proton™) systems.